相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach
Giovanni Targher et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review
Lydie Carreres et al.
BIOMEDICINES (2021)
Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies
Carmelo Luci et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
The role of IFN in the development of NAFLD and NASH
Michelle Mohlenberg et al.
CYTOKINE (2019)
Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions
Peter Lykke Eriksen et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2019)
Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study
Peter Lykke Eriksen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
Jingjing Cai et al.
HEPATOLOGY (2019)
Adipose type I interferon signalling protects against metabolic dysfunction
Verena Wieser et al.
GUT (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study
Ahmet Uygun et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)
Interferon Lambda 4 rs368234815 TT>δG Variant Is Associated With Liver Damage in Patients With Nonalcoholic Fatty Liver Disease
Salvatore Petta et al.
HEPATOLOGY (2017)
IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis
Mohammed Eslam et al.
NATURE GENETICS (2017)
Type I interferon responses drive intrahepatic T cells to promote metabolic syndrome
Magar Ghazarian et al.
SCIENCE IMMUNOLOGY (2017)
IFNL3/4 lgenotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection
K. S. O'Connor et al.
GENES AND IMMUNITY (2016)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
An integrated map of structural variation in 2,504 human genomes
Peter H. Sudmant et al.
NATURE (2015)
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
Mohammed Eslam et al.
NATURE COMMUNICATIONS (2015)
Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function
Karen Louise Thomsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Toll-Like Receptor 7-Mediated Type I Interferon Signaling Prevents Cholestasis- and Hepatotoxin-Induced Liver Fibrosis
Yoon Seok Roh et al.
HEPATOLOGY (2014)
Lymphocytes Degranulation in Liver in Hepatitis C Virus Carriers Is Associated With IFNL4 Polymorphisms and ALT Levels
Evelyne Jouvin-Marche et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Ewa Terczynska-Dyla et al.
NATURE COMMUNICATIONS (2014)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes
Pierre-Yves Bochud et al.
HEPATOLOGY (2012)
IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease
Salvatore Petta et al.
JOURNAL OF HEPATOLOGY (2012)
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort
Katherine R. Smith et al.
GENOME MEDICINE (2011)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43
Magdalena Sarasin-Filipowicz et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis
Ilker Tasci et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-β1 and α-smooth muscle actin in rats with hepatic fibrosis
Xin-Ming Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Effect of interferon-α on experimental septal fibrosis of the liver -: Study with a new model
MM de Souza et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2001)